Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement on the announcement by U.S. Treasury Secretary Geithner and Health and Human Services Secretary Sebelius of the recipients of the $1 billion Therapeutic Discovery Project: “Today’s announcement of Therapeutic Discovery Project (TDP) awards is an important first step toward the critical goals [...]

Bacteria have a natural ability to attach themselves to surfaces, both natural and synthetic. Once attached, they often work cooperatively to form biofilms, thin layers of bacterial colonies that can coat the surface of a medical device and introduce the risk of infection. As a result, orthopedic implants, catheters, and even contact lenses can become [...]

February 16, 2010 Abbott Park, Illinois (

Stay out of the OR with XIAFLEX…the biologics veterans at Auxilium Pharmaceuticals, Inc. have announced that the company has received marketing approval from the FDA for XIAFLEX (collagenase clostridium histolyticum) for the treatment of adult Dupuytren’s contracture patients with a palpable cord. In this condition, knots of connective tissue form under the skin and render [...]

Helix BioPharma Corp. (TSX, FSE: HBP; Pink Sheets: HXBPF) announced that the first ten patients that have been enrolled in its Phase II pharmacokinetic study of Topical Interferon Alpha-2b in patients with low-grade cervical lesions have completed the pharmacokinetic primary endpoint analyses with positive findings. All ten of these patients, at all sampling time points, [...]